Male hormones & fertility
Exogenous testosterone, spermatogenic suppression, and recovery after stopping
Last updated: October 2026 — Sources: Cochrane / EAU / ESHRE / WHO / CDC
Key takeaways
Testosterone is double-edged: essential for male function, but exogenous administration stops spermatogenesis. The commonest error in fertility clinics is prescribing testosterone to a man who wants to conceive — and correction is simple if the cause is identified early.
Exogenous testosterone suppresses LH/FSH and spermatogenesis — it is not a fertility treatment (Desai 2022).
After stopping: 67% reach 20 M/mL at 6 months, 90% at 12 months, 100% at 24 months.
TRAVERSE: no increase in major cardiac events with replacement (7.0% vs 7.3%, HR 0.96).
The alternative for men wanting to conceive: a SERM (clomiphene/tamoxifen) or hCG ± FSH under supervision.
When to evaluate?
- Acquired azoospermia after testosterone/steroid use — stop the cause first.
- Confirmed hypogonadism (twice <300 ng/dL) + symptoms + fertility wish — discuss alternatives.
- Erectile dysfunction or low libido with infertility — assess hormones and cause before treatment.
What not to do?
- Do not prescribe testosterone to a man planning conception within a year — it stops sperm production and recovery may take months.
- Do not start replacement without two fasting levels and symptoms — not a single symptom.
- Do not read TRAVERSE as a licence for testosterone in young healthy men — the population differs.
Healthcare-professional notice
This hub is independent of NPF products and does not promote them. It is informational only and does not replace individual clinical judgment. Surrogate outcomes (SDF, motility, HOMA, IIEF) are never converted into pregnancy/cure promises, and GRADE certainty is quoted as published.
Binding rule: surrogate outcomes are never converted into patient outcomes. Every certainty grade and limitation is quoted as published.
Deep dive
The axis and how it breaks
Exogenous testosterone exerts negative feedback at hypothalamus/pituitary → LH/FSH fall → intratesticular testosterone falls → spermatogenesis stops.
Recovery depends on duration, dose, age and baseline function — not injection duration alone.
SERM and hCG: how they work
A SERM blocks oestrogen feedback at the pituitary, raising LH/FSH — suitable for eugonadal or mild secondary cases.
hCG mimics LH to maintain Leydig cells, and FSH is needed for spermatogenesis — used in hypogonadotropic hypogonadism.
Evidence in this domain
Each study broken into five questions: why it was run, who was studied, how it was done, the finding, and why it came out that way — then the clinical takeaway and limits, as published.
FAQ
Is testosterone safe for the heart?
TRAVERSE showed non-inferiority vs placebo in men 45–80 with cardiac risk — but it does not answer for young healthy men or for fertility.
Notice: this reference is informational only and not a substitute for medical advice. Consult your doctor before making any treatment decision.